Immunology Division, Department of Pediatrics, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada.
J Immunol. 2010 Jul 1;185(1):357-66. doi: 10.4049/jimmunol.1000066. Epub 2010 Jun 2.
We have previously shown that naive CD8 T cells exposed to IL-7 or IL-15 in the presence of IL-21 undergo Ag-independent proliferation with concomitant increase in TCR sensitivity. In this study, we examined whether CD8 T cells that accumulate in suppressor of cytokine signaling 1 (SOCS1)-deficient mice because of increased IL-15 signaling in vivo would respond to an autoantigen expressed at a very low level using a mouse model of autoimmune diabetes. In this model, P14 TCR transgenic CD8 T cells (P14 cells) adoptively transferred to rat insulin promoter-glycoprotein (RIP-GP) mice, which express the cognate Ag in the islets, do not induce diabetes unless the donor cells are stimulated by exogenous Ag. Surprisingly, SOCS1-deficient P14 cells, which expanded robustly following IL-15 stimulation, proliferated poorly in response to Ag and failed to cause diabetes in RIP-GP mice. SOCS1-deficient CD8 T cells expressing a polyclonal TCR repertoire also showed defective expansion following in vivo Ag stimulation. Notwithstanding the Ag-specific proliferation defect, SOCS1-null P14 cells produced IFN-gamma and displayed potent cytolytic activity upon Ag stimulation, suggesting that SOCS1-null CD8 T cells underwent cytokine-driven functional differentiation that selectively compromised their proliferative response to Ag but not to cytokines. Cytokine-driven homeostatic expansion in lymphopenic RIP-GP mice allowed SOCS1-null, but not wild-type, P14 cells to exert their pathogenic potential even without Ag stimulation. These findings suggest that by attenuating cytokine-driven proliferation and functional differentiation, SOCS1 not only controls the pathogenicity of autoreactive cells but also preserves the ability of CD8 T cells to proliferate in response to Ags.
我们之前已经表明,在 IL-21 的存在下,幼稚 CD8 T 细胞暴露于 IL-7 或 IL-15 中会发生抗原非依赖性增殖,同时 TCR 敏感性增加。在这项研究中,我们检查了由于体内 IL-15 信号增加而在抑制细胞因子信号转导 1(SOCS1)缺陷小鼠中积累的 CD8 T 细胞是否会对自身抗原做出反应,该自身抗原在一种自身免疫性糖尿病的小鼠模型中以非常低的水平表达。在该模型中,过继转移到大鼠胰岛素启动子-糖蛋白(RIP-GP)小鼠中的 P14 TCR 转基因 CD8 T 细胞(P14 细胞)不会诱导糖尿病,除非供体细胞受到外源性抗原的刺激。令人惊讶的是,在 IL-15 刺激下大量扩增的 SOCS1 缺陷型 P14 细胞对抗原的增殖能力较差,并且不能在 RIP-GP 小鼠中引起糖尿病。表达多克隆 TCR 谱的 SOCS1 缺陷型 CD8 T 细胞在体内抗原刺激后也表现出增殖缺陷。尽管存在抗原特异性增殖缺陷,但 SOCS1 缺陷型 P14 细胞在抗原刺激下仍能产生 IFN-γ并显示出强大的细胞毒性活性,表明 SOCS1 缺陷型 CD8 T 细胞经历了细胞因子驱动的功能分化,这种分化选择性地损害了它们对抗原的增殖反应,但不损害对细胞因子的反应。在淋巴减少的 RIP-GP 小鼠中,细胞因子驱动的稳态扩张使 SOCS1 缺陷型而非野生型 P14 细胞即使没有抗原刺激也能发挥其致病潜能。这些发现表明,通过减弱细胞因子驱动的增殖和功能分化,SOCS1 不仅控制自身反应性细胞的致病性,而且还保留 CD8 T 细胞对抗原增殖的能力。